The apparent activation of the GHS-R1a receptor by Ipamorelin may lead to increased intracellular calcium ions through the phospholipase C pathway
Medications like Wegovy (semaglutide) and Saxenda (liraglutide) are FDA-approved specifically for weight loss
While this can support fat loss goals, it also creates a risk: Undereating key nutrients This is where diet becomes critical
By increasing growth hormone levels, Ipamorelin helps to enhance the bodys fat-burning capabilities, allowing individuals to achieve a leaner, more toned appearance
Peter discusses the effects of these medications on bone mass, fracture risk, strength, and physical function, highlighting why functional outcomes may be more important than body composition metrics alone
Cost factors are also important, as the formulated medication may differ in price compared to FDA-approved alternatives